首页> Current drug targets-The International journal for timely in-depth reviews on drug targets> The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder

The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder

导出原文传递

翻译打印收藏纠错

第一作者： Deang, Kanit Tha

作者： Deang, Kanit Tha ^[1] ; Sidi, Hatta ^[2] ; Zakaria, Hazli ^[3] ; Adam, Raja Lope ^[4] ; Das, Srijit ; Hatta, Nurul Hazwani ; Hatta, Muhammad Hizri ; Wee, Kok Wei

作者单位： Univ Kebangsaan Malaysia, Dept Psychiat, Fac Med, Med Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000 ^[1] Univ Sultan Zainal Abidin, Fac Med, Kampus Kota, Kuala Terengganu 20400, Malaysia ^[2] Natl Univ Galway, Galway, Ireland ^[3] Med Univ Warsaw, Warsaw, Poland ^[4]

关键词 Bupropion novel antidepressants treatment adult ADHD

发布时间 2019-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Current drug targets-The International journal for timely in-depth reviews on drug targets

2019年20卷2期

210-219页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Current drug targets-The International journal for timely in-depth reviews on drug targets

2019年20卷2期

210-219页

检索历史清除

The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder

Current drug targets-The International journal for timely in-depth reviews on drug targets

相似文献

同项目论文

Current drug targets-The International journal for timely in-depth reviews on drug targets

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder

Current drug targets-The International journal for timely in-depth reviews on drug targets

相似文献

同项目论文

Current drug targets-The International journal for timely in-depth reviews on drug targets

相关期刊

检索历史清除